Brendan M. Weiss, MD

Brendan M. Weiss is an Adjunct Assistant Professor of Medicine at Perelman School of Medicine, University of Pennsylvania. He completed his BS from Bucknell University and earned his medical degree from Uniformed Services University of The Health Sciences. Dr. Weiss is interested in the evaluation and management of patients with multiple myeloma, AL amyloidosis, and Waldenstrom's macroglobulinemia. He has a particular interest in the evaluation and management of myeloma precursor states, monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). In addition, he is interested in the other paraprotein-associated diseases such as monoclonal gammopathy of renal significance (MGRS), paraprotein associated neuropathy, cryoglobulinemia, POEMS syndrome and others.

Brendan Weiss is a hematologist-oncologist with a specific research and clinical interest in plasma cell disorders and related dysproteinemias like multiple myeloma, immunoglobulin light chain (AL) amyloidosis, and Waldenstrom's macroglobulinemia. He has lead the multi-disciplinary Penn Amyloidosis Program, which is a cross-disciplinary program involving clinicians with expertise in amyloidosis. Currently, Dr. Weiss is performing trials to develop and test novel biomarkers for progression in the myeloma precursor states (MGUS and SMM).